Content about Mylan Inc.

April 4, 2011
Mylan's generic Xalatan receives regulatory approval

The Food and Drug Administration has approved a generic drug made by Mylan that reduces pressure in the eye, Mylan said Monday.

March 29, 2011
Datamonitor: Global biosimilars market to reach nearly $4 billion by 2015

Any manufacturer that has the necessary resources and still is hesitating about whether to tap into biosimilars might want to go ahead and do it, if projections by British market analysis firm Datamonitor come true.

March 23, 2011
Mylan to launch educational site about generic drugs

Though more than 7-in-10 drugs dispensed in the United States today are generics, and the Food and Drug Administration holds generics to the same standards as branded drugs, misgivings among the general public still exist, fed by the occasional media report of patients experiencing bad side effects after taking certain generic drugs.

March 21, 2011
Report: Mylan looks to block Ranbaxy from making generic Lipitor

Generic drug maker Mylan is suing the Food and Drug Administration in an effort to prevent Gurgaon, India-based competitor Ranbaxy Labs from launching its generic version of Pfizer’s cholesterol medication Lipitor, according to published reports.

March 10, 2011
Under PEPFAR, Matrix Labs gets OK to sell zidovudine tablets

A subsidiary of Mylan has won approval to sell a generic drug for HIV and AIDS in developing countries under the President’s Emergency Plan for AIDS Relief.

March 4, 2011
ReportersNotebook — Chain Pharmacy, 3/14/11

SUPPLIER NEWS — Impax Labs received regulatory approval from the Food and Drug Administration for its generic version of a bacterial infection treatment. The drug maker said the FDA approved its 150-mg doxycycline monohydrate capsules, a drug used to treat bacterial infections and a generic version of Adoxa, made by Nycomed subsidiary PharmaDerm. The 150-mg strength of Adoxa had sales of about $25 million during the 12 months ended in December 2010, according to Wolters Kluwer.

March 2, 2011
Drug makers file suit against Mylan over generic Vivelle-Dot

A group of drug makers have sued Mylan over its attempt to gain Food and Drug Administration approval for a generic menopause drug, Mylan said Tuesday.

March 1, 2011
Heather Bresch, Robert Cindrich join Mylan's board

Mylan's board of directors now includes the drug maker's president.

March 1, 2011
Trial date set for generic Copaxone litigation

Teva on Tuesday said that a trial date has been set for its ongoing patent infringement litigation against several drug makers.

February 28, 2011
Matrix Labs' gabapentin capsules get FDA OK

The Food and Drug Administration has approved a treatment for shingles made by a subsidiary of generic drug maker Mylan.

February 22, 2011
GPhA announces executive committee, board of directors

The Generic Pharmaceutical Association has elected its 2011 executive committee and board of directors, the generic drug industry trade group announced. As part of a reorganization last year, the board has been reduced to 12 members.

February 15, 2011
Mylan gets approval for generic version of Vfend

Mylan has launched a generic drug for fungal infections, the company said Tuesday.

February 14, 2011
Report: Generic drug makers may look to diversify portfolios

An increase in consolidation among generic drug companies could be in the works, according to a new report from Thomson Reuters.

February 1, 2011
ReportersNotebook — Chain Pharmacy, 2/7/11

SUPPLIER NEWS — The Food and Drug Administration has approved a generic drug made by Watson Pharmaceuticals for cancer-related breakthrough pain, Watson said. The drug is a generic version of Cephalon’s Fentora, which had sales of around $179 million during the 12-month period ended in November 2010, according to IMS Health.





January 31, 2011
Mylan looks to market generic Lidoderm

Mylan has announced its intention to market a version of a painkiller made by Endo Pharmaceuticals and partner company Teikoku Seiyaku ahead of patent expiration.

January 28, 2011
Mylan's generic Sular gets FDA OK

The Food and Drug Administration has approved a generic hypertension treatment made by Mylan.

January 27, 2011
Matrix obtains license agreement for HIV treatment

A Mylan subsidiary has inked a nonexclusive license agreement with Tibotec Pharmaceuticals to manufacture, market and distribute a generic version of an HIV treatment.

January 25, 2011
Mylan announces Lipitor, Caduet patent settlements

Generic drug maker Mylan has entered settlements with Pfizer concerning two drugs for treating cholesterol.

January 20, 2011
Under PEPFAR, Matrix gets tentative approval for generic Combivir

The Food and Drug Administration has given tentative approval to an antiretroviral treatment for children with HIV and AIDS under the President’s Emergency Plan for AIDS Relief program.

January 18, 2011
Mylan's generic Precose gets green light from FDA

The Food and Drug Administration has approved a generic diabetes drug made by Mylan, the drug maker said Tuesday.

January 5, 2011
ReportersNotebook — Chain Pharmacy, 1/10/11

Supplier News — The Food and Drug Administration has approved a generic drug for hypertension made by Mylan. Mylan announced the approval of nifedipine extended-release tablets in the 30-mg, 60-mg and 90-mg strengths. The drug is a generic version of Bayer’s Adalat CC. Nifedipine tablets had sales of around $82 million during the 12-month period ended June 2010, according to IMS Health.



 

January 4, 2011
Mylan settles Medicaid reimbursement suit

Generic drug maker Mylan has settled a lawsuit concerning Medicaid reimbursements with the federal government and the state of Texas, Mylan said Dec. 24.

December 22, 2010
Takeda settles patent suits relating to Actos

Takeda and its subsidiary settled the patent suits it brought against generic drug makers that sought to develop their own versions of its diabetes treatment.

December 21, 2010
Court blocks AstraZeneca's suits over Crestor

A judge recently blocked AstraZeneca from attempting to impede the development of generic versions of its popular cholesterol drug, according to published reports.

December 21, 2010
Dey Pharma settles DoJ suit

A Mylan subsidiary has settled a lawsuit brought on by the Department of Justice four years ago.

© 2013 Drug Store News. All Rights Reserved.